US FDA seeks input on drug naming guidance to reduce medication errors
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is seeking stakeholder feedback on its plans to prepare preliminary guidance on the naming, labelling and packaging of medicines to reduce medication errors1.